Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Antiviral Res. 2017 Nov 8;149:26–33. doi: 10.1016/j.antiviral.2017.10.022

Figure 4.

Figure 4

Antiviral effects of entecavir, REP 2055 and REP 2031 in HBV infected SCID-Hu mice. Changes in body weight (A), serum human albumin (B), HBsAg (C), HBeAg (D) and HBV DNA (E) are presented. Plotted values are mean ± standard deviation (n=5).